Dr Andrew Streets BSc MSc PhD

Senior Research Fellow in Nephrology

Photo of Dr Andrew Streets

Academic Nephrology Unit, K122a
Royal Hallamshire Hospital
The Medical School
University of Sheffield
Beech Hill Road
S10 2RX
United Kingdom

Tel: +44 (0)114 271 2365
Email: a.j.streets@sheffield.ac.uk


I obtained a BSc (Hons) from the University of Durham in 1993, an MSc from UCL in 1996 and completed my PhD at the University of Leeds in 2000. I joined the University of Sheffield in 1999 working in the Kidney Genetics Group headed by Professor Albert Ong. After completing a Kidney Research UK Career Development Fellowship I was awarded an RCUK Academic Fellowship in 2006 with support from the Sheffield Kidney Research Foundation.  I currently hold the title of Senior Research Fellow in Nephrology.

Research Interests

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disease affecting the kidney (incidence 1 in 1000) and is caused by mutations in two genes, PKD1 (85-90%) or PKD2 (10-15%) which encode the polycystin-1 and 2 proteins respectively. Around 10% of patients on renal replacement therapy have ADPKD and it is estimated that this treatment costs £40 million per annum to the NHS alone. There are currently no effective drugs for slowing progression in the 50% of ADPKD patients who are destined to develop end-stage renal failure.

The aim of my current research is to test the hypothesis that the biology of the polycystin-1 and 2 complex is regulated by reversible protein phosphorylation under the control of tightly regulated protein kinases and phosphatases. Reversible phosphorylation regulates protein trafficking, protein-protein interactions and protein functions such as cell-cell adhesion, channel activity and cell signalling. Polycystin-1 and 2 can act either as part of a complex, or as individual proteins to carry out these functions. Understanding this dynamic process will provide important new information which could lead to new treatments to retard cyst formation in ADPKD. My recent work has shown that phosphorylation plays a key role in regulating polycystin-2 function both in vitro and in vivo and that polycystin-1 regulates cell adhesion, both of which are critically important for the maintenance of normal tubular and glomerular morphology.

Teaching Intersts

I teach on the following courses:

  • Molecular Biology and Biochemistry undergraduate module MBB334
  • MSc Molecular Medicine modules MED6002, 6003 and 6005

Current Projects

My research has been funded by the RCUK, KRUK, SKRF, ERA-EDTA and the Northern General Hospital trustees as well as the Medical School.

My current projects include:

  1. The role of phosphorylation in the regulation of polycystin-2 function.
  2. The role of polycystin 1 and 2 in the regulation of cell adhesion.
  3. The role of microRNAs in the pathogenesis of ADPKD.

Key Publications

  1. Streets AJ, Wessely O, Peters DJ, Ong AC. Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for poycystin-1-regulated dephosphorylation.  Hum Mol Genet. 2013 22 1924-39.
  2. Chou CY, Streets AJ, Watson PF, Huang L, Verderio EA, Johnson TS.  A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.   J Biol Chem. 2011 286 27825-35.
  3. Mao Z, Streets AJ, Ong AC. Thiazolidinediones inhibit MDCK cyst growth through disrupting oriented cell division and apicobasal polarity.  Am J Physiol Renal Physiol. 2011 300 F1375-84.
  4. Streets, AJ, Needham, AJ, Gill, SK and Ong AC.  Protein kinase D-mediated phosphorylation of polycystin-2 (TRPP2) is essential for its effects on cell growth and calcium channel activity. Mol Biol Cell. 2010 21 3853-65.
  5. Streets, AJ, Wagner BE, Harris, PC, Ward CJ & Ong AC. Homophilic and heterophilic polycystin-1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells. J Cell Science. 2009 122 1410-7.
  6. Feng, S, Okenka, GM, Bai, CX, Streets, AJ, Newby, LJ, DeChant, BT, Tsiokas, L, Obara, T & Ong, AC. Identification and functional characterization of an N-terminal oligomerization domain for polycystin-2. J Biol Chem. 2008 283 28471-9.
  7. Bai CX, Kim S, Li WP, Streets AJ, Ong AC, Tsiokas L. Activation of TRPP2 through mDia1-dependent voltage gating. EMBO J. 2008, 27 1345-56.
  8. Parker E, Newby LJ, Sharpe CC, Rossetti S, Streets AJ, Harris PC, O'Hare MJ, Ong AC. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system. Kidney Int. 2007 72 157-65.
  9. Streets AJ, Moon DJ, Kane ME, Obara T and Ong ACM. Identification of an N-terminal glycogen synthase kinase 3 phosphorylation site which regulates the functional localisation of polycystin-2 in vivo and in vitro. Hum Mol Genet. 2006 15 1465-73.
  10. Streets AJ, Newby L, O'Hare M, Bukanov N, Ibraghimov-Beskrovnaya O, Ong ACM. Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion. J Am Soc Nephrol. 2003 14 1804-15.
  11. Newby LJ, Streets AJ, Zhao Y, Harris PC, Ward CJ, Ong ACM. Identification, characterisation and localisation of a novel kidney polycystin-1/polycystin-2 complex. J Biol Chem. 2002 277 20763-73 (joint first author).
  12. Dwek MV, Ross HA, Streets AJ, Brooks SA, Adam E, Titcomb A, Woodside JV, Schumacher U, Leathem AJ. Helix pomatia agglutinin lectin-binding oligosaccharides of aggressive breast cancer. Int J Cancer. 2001 95 79-85.
  13. Baldwin SA, Barros LF, Griffiths M, Ingram J, Robbins EC, Streets AJ, Saklatvala J. Regulation of GLUT1 in response to cellular stress. Biochem Soc Trans. 1997 25 954-958.
  14. Dwek MV, Brooks SA, Streets AJ, Harvey DJ, Leathem AJ. Oligosaccharide release from frozen and paraffin-wax-embedded archival tissues. Anal Biochem. 1996 242 8-14.
  15. Streets AJ, Brooks SA, Dwek MV, Leathem AJ. Identification, purification and analysis of a 55 kDa lectin binding glycoprotein present in breast cancer tissue. Clin Chim Acta. 1996 254 47-61.